QTTB

Conviction 85HealthcareScan · Fri, Jun 26, 2026

QTTB$13.01+8.87%

ResistanceSupportVol 14Insider buy

Vol MA14 453.87K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Q32 Bio Inc.PHARMACEUTICAL PREPARATIONSwww.q32bio.com ↗

Price13.01

Change+8.87%

Gap+2.05%

Rel volume1.27×

Avg volume588.27K

Avg $ vol7.29M

SMA 2012.39

SMA 508.68

SMA 2004.95

Price vs 50+49.83%

Price vs 200+162.94%

MA stackbullish

50/200 cross—

Supertrendup · 8.85

RSI (14)60

MACD hist-0.26

MACD crossbear · 7d

Stoch %K / %D72 / 40

ADX (14)35

+DI / −DI23 / 16

RSI divergence—

MACD divergence—

ATR %+10.66%

ADR %12.40%

52w high14.00

52w low1.36

From 52w high-7.07%

Above 52w low+856.62%

New 52w highNo

SqueezeOff

Bollinger width22.35%

%B0.72

Donchian pos59.11%

Donchian high14.85

Donchian low10.35

AVWAP (52w high)12.67

vs AVWAP high+2.71%

AVWAP (52w low)4.88

vs AVWAP low+166.51%

OBV trendUp

Chaikin MF (20)-0.01

Today vs 20d1.27×

Avg vol (14d)453.87K

Avg vol (20d)588.27K

Avg $ vol (20d)7.29M

Market cap—

RS 3m (vs SPY)+53.03%

RS 6m (vs SPY)+287.17%

RS line new highNo

Trend template8/8

Technical rank96.7

1 week+9.33%

1 month+1.25%

3 months+82.21%

6 months+316.99%

1 year+733.97%

YTD+278.20%

P/E6.78

P/B4.36

P/S174.84

P/FCF-6.03

EPS2.42

Div yield—

ROE64.39%

ROA46.83%

Debt/Eq—

Current5.36

EV/EBITDA—

Gross margin—

Net margin—

Rev growth-63.97%

EPS growth162.47%

Price target12.33

Target upside3.44%

Analyst ratingBuy

Institutional56.91%

Ent. value151.37M

Revenue0

Net income-7.61M

Gross profit—

Free cash flow-33.54M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out16.96M

Employees22

ListedTue, Mar 26, 2024

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction85 / 100

Pattern quality—

Tech rank96.7 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance14.28

Support5.00

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in QTTB

All disclosures →

No recent disclosed trades by Congress in QTTB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in QTTB · 8 buys

Insider	Side	Shares	Value	Traded	Filed
OrbiMed Genesis GP LLC Director · Common Stock · 2026-05-28	Buy	625K	$5.0M	2026-05-28	2026-06-01
ORBIMED ADVISORS LLC Director · Common Stock · 2026-05-28	Buy	625K	$5.0M	2026-05-28	2026-06-01
OrbiMed Capital GP VII LLC Director · Common Stock · 2026-05-28	Buy	625K	$5.0M	2026-05-28	2026-06-01
OrbiMed Genesis GP LLC Director · Common Stock · 2026-05-28	Buy	1.25M	$10M	2026-05-28	2026-06-01
ORBIMED ADVISORS LLC Director · Common Stock · 2026-05-28	Buy	1.25M	$10M	2026-05-28	2026-06-01
Xu Diyong Director · Common Stock · 2026-05-28	Buy	1.25M	$10M	2026-05-28	2026-06-01
OrbiMed Capital GP VII LLC Director · Common Stock · 2026-05-28	Buy	1.25M	$10M	2026-05-28	2026-06-01
Xu Diyong Director · Common Stock · 2026-05-28	Buy	625K	$5.0M	2026-05-28	2026-06-01

SEC filings

EDGAR filings in QTTB · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.